Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Non-cash Items (2016 - 2019)

Neurocrine Biosciences (NBIX) has disclosed Non-cash Items for 7 consecutive years, with $3.9 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Non-cash Items fell 7.14% year-over-year to $3.9 million, compared with a TTM value of $3.9 million through Dec 2018, down 7.14%, and an annual FY2018 reading of $3.9 million, down 7.14% over the prior year.
  • Non-cash Items was $3.9 million for Q4 2018 at Neurocrine Biosciences, down from $4.2 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $4.5 million in Q4 2016 and bottomed at $3.8 million in Q4 2015.
  • Average Non-cash Items over 5 years is $4.1 million, with a median of $4.2 million recorded in 2014.
  • The sharpest move saw Non-cash Items dropped 9.52% in 2015, then grew 18.42% in 2016.
  • Year by year, Non-cash Items stood at $4.2 million in 2014, then decreased by 9.52% to $3.8 million in 2015, then rose by 18.42% to $4.5 million in 2016, then decreased by 6.67% to $4.2 million in 2017, then fell by 7.14% to $3.9 million in 2018.
  • Business Quant data shows Non-cash Items for NBIX at $3.9 million in Q4 2018, $4.2 million in Q4 2017, and $4.5 million in Q4 2016.